Organon & Co. · NYSE:OGN

Karp Daniel exercised options for 18,053 Organon & Co. shares (Form 4)

Traded Mar 31, 2026 · Filed Apr 2, 2026

On Mar 31, 2026, Karp Daniel (Executive VP, Corp. Dev.) exercised options for 18,053 Organon & Co. shares, leaving 69,548 shares. Filed Apr 2, 2026 (Form 4).

Options exercised
18,053 shares
Holding after
69,548 shares
Trading plan
No
Role
Executive VP, Corp. Dev.

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Mar 31, 2026Common StockOption exercise11,33868,492Direct
Mar 31, 2026Common StockShares withheld for tax3,554US$5.7064,938Direct
Mar 31, 2026Common StockOption exercise6,71571,653Direct
Mar 31, 2026Common StockShares withheld for tax2,105US$5.7069,548Direct

Source

View original at SEC

Related